selective estrogen receptor degrader SRN-927
Term · Oncology and biomedicine · MLC-T-ONC-016671
An orally available, nonsteroidal selective estrogen receptor degrader (SERD), with potential antineoplastic activity. Upon oral administration, SERD SRN-927 specifically binds to the estrogen receptor (ER) and induces a conformational change that results in the degradation of the receptor. This prevents ER-mediated signaling and inhibits the growth and survival of ER-expressing cancer cells.
| Identifier | MLC-T-ONC-016671 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | SERD SRN-927 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016671",
"term": "selective estrogen receptor degrader SRN-927",
"field": "Oncology and biomedicine",
"definition": "An orally available, nonsteroidal selective estrogen receptor degrader (SERD), with potential antineoplastic activity. Upon oral administration, SERD SRN-927 specifically binds to the estrogen receptor (ER) and induces a conformational change that results in the degradation of the receptor. This prevents ER-mediated signaling and inhibits the growth and survival of ER-expressing cancer cells.",
"synonyms": [
"SERD SRN-927"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/selective-estrogen-receptor-degrader-srn-927/"
}
Record 14,803 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.